Search - tctmd.com

Displaying 1 - 20 of 34

Sort: Relevancy | Date

Presentation TCT 2025

TCT 318: Stroke after TAVR - Impact on Clinical Outcome and Patient Reported Quality of Life (QoL): The Michigan Structural Heart Consortium (MISHC) Experience

Presenter: P. Michael Grossman

October 26, 2025

News Conference News TCT 2024

Pooled All-Female Analysis Support Benefits of TAVI Over SAVR

L.A. McKeown

November 01, 2024

News Conference News TCT 2024

TRISCEND II: Full Results a Win for TTVR in Severe Tricuspid Regurgitation

Michael O'Riordan

October 30, 2024

Presentation TCT 2024

Japan Academic Perspective: The Patient’s View of QOL in Japan

Presenter: Koichiro Kinugawa

October 29, 2024

News Conference News TCT 2023

SUMMIT: MV Replacement With Tendyne Shows Promise in Severe MR, MAC

Yael L. Maxwell

October 30, 2023

News Conference News TCT 2023

TRILUMINATE Deep Dive Clarifies ‘Meaningful’ QoL Gains With Tricuspid TEER

Yael L. Maxwell

October 26, 2023

Presentation TCT 2023

Validation of the Kansas City Cardiomyopathy Questionnaire in Patients With Tricuspid Regurgitation: The Tri-QOL Study

Presenter: Suzanne Arnold

October 25, 2023

News Conference News TCT 2022

Pre-AVR Cardiac Damage in PARTNER Patients Linked to Poorer QoL at 1 Year

L.A. McKeown

September 23, 2022

News Conference News TCT 2022

TRILUMINATE Pivotal Trial: First Data Support Safety, Efficacy of TriClip

Caitlin E. Cox

September 17, 2022

News Conference News TCT 2020

Acurate Neo Still Falls Short of Sapien 3 in SCOPE 1-Year Follow-up

Michael O'Riordan

October 23, 2020

News Conference News TCT 2020

Global EXPAND: Next-Gen MitraClip Cuts MR, Boosts QoL at 1 Year

L.A. McKeown

October 16, 2020

News Conference News TCT 2019

‘Spooky’ Signal Still Haunts Paclitaxel DCBs in PAD, but Updated Analysis Reassures

L.A. McKeown

September 28, 2019

News Conference News TCT 2018

Transcatheter Mitral Valve Repair Provides Fast, Sustained Gains in Quality of Life

TCT Daily Staff

September 27, 2018

Presentation TCT 2018

PCI for Ischemia Part II: Why the ISCHEMIA Trial Might be Positive..or Negative!

Presenter: David J. Cohen, Sunil V. Rao, Ajay J. Kirtane

September 22, 2018

Presentation TCT 2018

PCI for Ischemia Part I: Critical Analysis of the FAME Trials and ORBITA

Presenter: David J. Cohen, Sunil V. Rao, Bernard J. Gersh

September 22, 2018

Presentation TCT 2018

Increasing Emphasis on QOL Outcomes: From Patient Preference to Instrument Validation

Presenter: David J. Cohen, Sunil V. Rao, John A. Spertus

September 22, 2018

Presentation TCT 2018

Optimal Medical Therapy With and Without Coronary Revascularization: Which Drugs Matter? Symptoms, Ischemia, or Prognosis? And Magnitude of Impact

Presenter: David J. Cohen, Sunil V. Rao, David J. Maron

September 22, 2018

News Conference News TCT 2017

FAME 2 at 3 Years: Outcomes, Symptoms Better With PCI vs OMT in Stable CAD, at Similar Cost

L.A. McKeown

November 02, 2017

Presentation TCT 2017

Topic 3: Chronic Total Occlusion PCI - What Level of Evidence Is Required for Widespread Acceptance: Hard Endpoints vs QOL Measures

Presenter: Robert A. Byrne, Gregg W. Stone, J. Aaron Grantham

October 30, 2017

News Conference News TCT 2017

Live From Denver: TCT 2017, Day One

Shelley Wood

October 30, 2017

Advertisement

TCT 318: Stroke after TAVR - Impact on Clinical Outcome and Patient Reported Quality of Life (QoL): The Michigan Structural Heart Consortium (MISHC) Experience

Pooled All-Female Analysis Support Benefits of TAVI Over SAVR

TRISCEND II: Full Results a Win for TTVR in Severe Tricuspid Regurgitation

Japan Academic Perspective: The Patient’s View of QOL in Japan

SUMMIT: MV Replacement With Tendyne Shows Promise in Severe MR, MAC

TRILUMINATE Deep Dive Clarifies ‘Meaningful’ QoL Gains With Tricuspid TEER

Validation of the Kansas City Cardiomyopathy Questionnaire in Patients With Tricuspid Regurgitation: The Tri-QOL Study

Pre-AVR Cardiac Damage in PARTNER Patients Linked to Poorer QoL at 1 Year

TRILUMINATE Pivotal Trial: First Data Support Safety, Efficacy of TriClip

Acurate Neo Still Falls Short of Sapien 3 in SCOPE 1-Year Follow-up

Global EXPAND: Next-Gen MitraClip Cuts MR, Boosts QoL at 1 Year

‘Spooky’ Signal Still Haunts Paclitaxel DCBs in PAD, but Updated Analysis Reassures

Transcatheter Mitral Valve Repair Provides Fast, Sustained Gains in Quality of Life

PCI for Ischemia Part II: Why the ISCHEMIA Trial Might be Positive..or Negative!

PCI for Ischemia Part I: Critical Analysis of the FAME Trials and ORBITA

Increasing Emphasis on QOL Outcomes: From Patient Preference to Instrument Validation

Optimal Medical Therapy With and Without Coronary Revascularization: Which Drugs Matter? Symptoms, Ischemia, or Prognosis? And Magnitude of Impact

FAME 2 at 3 Years: Outcomes, Symptoms Better With PCI vs OMT in Stable CAD, at Similar Cost

Topic 3: Chronic Total Occlusion PCI - What Level of Evidence Is Required for Widespread Acceptance: Hard Endpoints vs QOL Measures

Live From Denver: TCT 2017, Day One

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content